dc.contributor | Prias Mogro Leila | |
dc.contributor | Soledispa Cañarte Pilar Asunción | |
dc.creator | Morán Iza, Eddy Aldahir | |
dc.creator | Reyes Tituana, John William | |
dc.date.accessioned | 2019-06-13T14:42:27Z | |
dc.date.accessioned | 2023-03-09T15:06:43Z | |
dc.date.available | 2019-06-13T14:42:27Z | |
dc.date.available | 2023-03-09T15:06:43Z | |
dc.date.created | 2019-06-13T14:42:27Z | |
dc.date.issued | 2019 | |
dc.identifier | BCIEQ-T-0392 | |
dc.identifier | http://repositorio.ug.edu.ec/handle/redug/40864 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/6070833 | |
dc.description.abstract | En el presente trabajo, se analizó las propiedades terapéuticas y farmacológicas presentes en el extracto etanólico del rizoma Smilax. Se conformaron 5 grupos de 6 ratones albinos OF-1. Se aplicó en la oreja derecha el agente inductor (aceite de Crotón), produciéndose el edema. Luego, se aplicaron los diferentes tratamientos: El grupo (A) control negativo sin tratamiento, (B) control positivo (Ketorolaco), los grupos (C, D, E) tratados con extracto en dosis (mg/kg): 100, 500, 250 respectivamente. Transcurridas 6 horas se dio eutanasia a los animales, se cortó las orejas y se obtuvo disco de 6 mm de diámetro (oreja derecha e izquierda) y se los pesó. Al finalizar el estudio se obtuvo como resultado los siguientes promedios (oreja derecha): (A) 0.0110±0.0011; (B) 0.0110±0.0020; (C) 0.0012±0.0012; (D) 0.0118±0.0028; (E) 0.0115 ±
0.0022.g El porcentaje de inhibición (A) 0, (B) (78%), (C) (74.64%), (D) (44.84%), (E) (33.17%). Se presentó diferencia significativa de p<0.05 entre grupos, siendo que el grupo C de 1000 mg/Kg; presentó mayor inhibición después del fármaco control; por lo tanto, en el respectivo análisis de resultados se logró demostrar que el extracto si presentaba inhibición de la inflamación en la dosis mayor (1 000 mg). | |
dc.description.abstract | In the present work, the therapeutic and pharmacological properties present in the ethanolic extract of the Smilax rhizome were analyzed. Five groups of 6 albino OF-1 mice were formed. The inducing agent (Croton oil) was applied to the right ear, producing edema. Then, the different treatments were applied: The group (A) negative control without treatment, (B) positive control (Ketorolac), the groups (C, D, E) treated with extract in dose (mg / kg): 1000, 500, 250 respectively. After
6 hours the animals were euthanized, the ears were cut, a 6 mm diameter disc was obtained (right and left ear) and weighed. At the end of the study, the following averages were obtained (right ear): (A)
0.0110 ± 0.0011; (B) 0.0110 ± 0.0020; (C) 0.0012 ± 0.0012; (D) 0.0118
± 0.0028; (E) 0.0115 ± 0.0022.g The percent inhibition was (A) 0, (B) (78%), (C) (74.64%), (D) (44.84%), (E) (33.17%). There was a significant difference of p <0.05 between groups, being that group C of
1000 mg / Kg; showed greater inhibition after the control drug; therefore, in the respective analysis of results it was possible to demonstrate that the extract did present inhibition of inflammation in the highest dose (1000 mg / kg). | |
dc.language | spa | |
dc.publisher | Universidad de Guayaquil. Facultad de Ciencias Químicas | |
dc.rights | openAccess | |
dc.subject | RIZOMA | |
dc.subject | ACEITE DE CROTÓN | |
dc.subject | EDEMA | |
dc.subject | KETOROLACO | |
dc.title | Evaluación de actividad antiinflamatoria del extracto etanólico del rizoma Smilax domingensis Willd cultivada en Cuba | |
dc.type | Thesis | |